CoSo Health to Distribute Medinol’s EluNIR DES in the United States

June 2, 2023—CoSo Health recently announced a United States distribution agreement with Medinol Ltd. for its new-generation, thin-strut EluNIR drug-eluting stent (DES). CoSo Health uses a cloud-based logistics platform and customized direct-to–end user delivery model to distribute and sell devices.

CoSo Health will work with U.S. Endovascular, which sells peripheral and coronary devices nationwide, and others to reach the United States market. Successive generations of EluNIR are expected to be introduced to the global market soon, advised CoSo Health.

According to CoSo Health, Medinol’s EluNIR DES offers excellent clinical outcomes and an outstanding safety profile. The device features a best-in-class metal-to-artery ratio, an ultra-durable polymer coating, and a unique delivery system.